German climate-tech startup AIRMO secures €5M to launch satellites that detect unreported methane emissions, helping industries and governments cut greenhouse gases.
Author: Elyse Christian
VALANX Biotech secures €3M to push its lead antibody-drug conjugate program toward safer, more precise cancer treatment.
Bladder cancer innovator Combat Medical has raised £2.6M to hit a key phase 3 milestone, accelerating development of its heat-enhanced intravesical therapy.
French startup Mantle8 secures a €2.06M EU Just Transition Fund grant to accelerate natural hydrogen exploration and support Europe’s low-carbon energy transition.
Paris-based biotech startup baCta secures €7M to engineer microorganisms as programmable molecular factories, targeting faster, cleaner industrial biomanufacturing.
Cardiovascular biotech startup SignaCor Therapeutics raises a €1.1M seed round, including a €288k investment, to advance precision therapies for heart disease.
Scottish medtech firm BIOCAPTIVA raises £1.58M and rolls out its first liquid biopsy kits in the US, aiming to transform early cancer detection and clinical research.
German startup nyra health secures €20M to expand its AI-driven neurotherapy platform and tackle Europe’s €65B neurological care gap.
The United States drafts a new framework for artificial intelligence exports, potentially requiring foreign investments in domestic data centers for large shipments. The federal government of the United States is currently evaluating a comprehensive regulatory structure governing the international distribution of advanced artificial intelligence semiconductors. Internal documentation recently reviewed by the news organization Reuters indicates that federal officials are contemplating stringent new stipulations for allied nations seeking to acquire these critical technological components in massive quantities. Under the proposed guidelines, any foreign government or international corporate entity attempting to secure an export license for shipments exceeding two hundred thousand advanced…
Vast raises $500M led by Balerion Space Ventures to fast‑track its Haven commercial space stations and position itself as a key successor to the ISS.